FHOD1 and central nervous system cancer: In addition to triple-negative breast cancer, FHOD1 expression has been observed to be significantly uppregulated in glioma cells, a change that correlated strongly with the degree of malignancy and aggressiveness of gliomas, as well as with the prognosis of patients (14).